![Chronic COVID syndrome: a new study shows the positive effects of using Apportal, a targeted nutritional supplement Chronic COVID syndrome: a new study shows the positive effects of using Apportal, a targeted nutritional supplement](https://www.nutraingredients.com/var/wrbm_gb_food_pharma/storage/images/publications/pharmaceutical-science/outsourcing-pharma.com/suppliers/pharmanutra-spa/12365130-4-eng-GB/PharmaNutra-Spa.png)
Chronic COVID syndrome: a new study shows the positive effects of using Apportal, a targeted nutritional supplement
![Chronic COVID syndrome: a new study shows the positive effects of using Apportal, a targeted nutritional Chronic COVID syndrome: a new study shows the positive effects of using Apportal, a targeted nutritional](https://www.nutraingredients.com/var/wrbm_gb_food_pharma/storage/images/_aliases/promo_feature_cover/publications/food-beverage-nutrition/nutraingredients.com/news/promotional-features/chronic-covid-syndrome-a-new-study-shows-the-positive-effects-of-using-apportal-a-targeted-nutritional-supplement/12365031-1-eng-GB/Chronic-COVID-syndrome-a-new-study-shows-the-positive-effects-of-using-Apportal-a-targeted-nutritional-supplement.jpg)
Chronic COVID syndrome: a new study shows the positive effects of using Apportal, a targeted nutritional
![Junia Pharma lancia sul mercato il nuovo ApportAL® Vital - Junia Pharma - Salute di bambini e neonati Junia Pharma lancia sul mercato il nuovo ApportAL® Vital - Junia Pharma - Salute di bambini e neonati](https://juniapharma.it/wp-content/uploads/2022/09/junia-pharma-news-lancio-apportal-vital.png)
Junia Pharma lancia sul mercato il nuovo ApportAL® Vital - Junia Pharma - Salute di bambini e neonati
![ITALIA ECONOMY - PHARMANUTRA S.P.A. LANCIA SUL MERCATO I NUOVI PRODOTTI CETILAR® ORO E APPORTAL® VITAL ITALIA ECONOMY - PHARMANUTRA S.P.A. LANCIA SUL MERCATO I NUOVI PRODOTTI CETILAR® ORO E APPORTAL® VITAL](https://italiaeconomy.it/wp-content/uploads/2022/09/Cetilar-ORO-AW-2022-scaled.jpg.webp)